MFDS — authorised 20 December 2019
- Marketing authorisation holder: DAIICHI SANKYO
- Status: likely_approved
🇰🇷 Enhertu in South Korea
MFDS authorised Enhertu on 20 December 2019
Marketing authorisation
Enhertu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Enhertu approved in South Korea?
Yes. MFDS authorised it on 20 December 2019.
Who is the marketing authorisation holder for Enhertu in South Korea?
DAIICHI SANKYO holds the South Korean marketing authorisation.